Plasma biomarkers correlating with clinical outcome in a phase II study of sorafenib in advanced NSCLC

George R. Blumenschein, Martin Reck, Frank Fossella, David J. Stewart, Chetan Lathia, Carol Peña

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Plasma biomarkers correlating with clinical outcome in a phase II study of sorafenib in advanced NSCLC'. Together they form a unique fingerprint.

Medicine & Life Sciences